HEC68498

Sunshine Lake Pharma Co., Ltd. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	HEC68498
Sponsor	Sunshine Lake Pharma Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (PHASE1)
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HEC68498 CI brief — competitive landscape report
HEC68498 updates RSS · CI watch RSS
Sunshine Lake Pharma Co., Ltd. portfolio CI